At the news
? BULLISHIMPACT 5/10 COURT-RULING filed Jun 25, 2026 at 20:00 ET
The Delaware Chancery Court granted Alcon's motion to dismiss all six counts in a derivative lawsuit challenging conduct related to Aurion Biotech's IPO. The court found the IPO was postponed before Alcon became a controlling stockholder and that the board's inaction did not constitute a fiduciary breach. This ruling removes litigation uncertainty for Alcon.
- All six counts of the derivative complaint dismissed under Rule 12(b)(6).
- IPO was postponed on Feb 6, 2025, before Alcon's February actions challenged in the suit.
- Court held that directors are presumed to act in good faith and that Plaintiff's disagreement with business decisions is insufficient.
- No damages awarded; no injunction issued.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access